ARVINAS, INC. Amortization of Debt Discount (Premium)
ARVINAS, INC. (ARVN) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2021-03-01
- ARVINAS, INC. amortization of debt discount (premium) for the quarter ending 2020-12-31 was $0.00.
- ARVINAS, INC. amortization of debt discount (premium) for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- ARVINAS, INC. amortization of debt discount (premium) for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- ARVINAS, INC. amortization of debt discount (premium) for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- ARVINAS, INC. amortization of debt discount (premium) for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- ARVINAS, INC. amortization of debt discount (premium) for fiscal 2019 was $15.15K, a 15.67% decline from fiscal 2018.
- ARVINAS, INC. amortization of debt discount (premium) for fiscal 2018 was $17.96K, a 0.00% change from fiscal 2017.
- ARVINAS, INC. amortization of debt discount (premium) for fiscal 2017 was $17.96K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $0.00 10-Q · filed 2020-08-04 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $6.17K derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-03-31 | $0.00 10-Q · filed 2020-04-28 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $6.17K derived: sum of 3 quarters · filed 2021-03-01 | $10.66K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $6.17K derived: sum of 2 quarters · filed 2021-03-01 | $10.66K derived: sum of 3 quarters · filed 2021-03-01 | $15.15K 10-K · filed 2021-03-01 |
| 2019-09-30 | $6.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $10.66K derived: sum of 2 quarters · filed 2020-11-05 | $15.15K 10-Q · filed 2020-11-05 | $19.64K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $4.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $8.98K 10-Q · filed 2020-08-04 | $13.47K derived: sum of 3 quarters · filed 2021-03-01 | $22.45K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $4.49K 10-Q · filed 2020-04-28 | $8.98K derived: sum of 2 quarters · filed 2021-03-01 | $17.96K derived: sum of 3 quarters · filed 2021-03-01 | $17.96K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $4.49K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $13.47K derived: sum of 2 quarters · filed 2021-03-01 | $13.47K derived: sum of 3 quarters · filed 2021-03-01 | $17.96K 10-K · filed 2021-03-01 |
| 2018-09-30 | $8.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $8.98K derived: sum of 2 quarters · filed 2019-11-04 | $13.47K 10-Q · filed 2019-11-04 | $17.96K derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $4.49K 10-Q · filed 2019-08-05 | $8.98K derived: sum of 3 quarters · filed 2019-08-05 | |
| 2018-03-31 | $4.49K 10-Q · filed 2019-05-09 | $8.98K derived: sum of 2 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $4.49K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $17.96K 10-K · filed 2019-03-26 | ||
| 2017-09-30 | $13.47K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |